Alamar Biosciences Stock

alamarbio.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $120.9MM

Alamar biosciences developing medical platforms in the field of proteomics to enable the early detection of cancer and other diseases.

Register for Details

For more details on financing and valuation for Alamar Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Alamar Biosciences.

Register Today

Other companies like Alamar Biosciences in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Alamar Biosciences, Abcam Partner for Proteomics Research
The companies aim to bring together Alamar's immunoassay-based NULISA proteomics platform and Abcam's extensive antibody portfolio.
Updated on: Sep 26, 2023